Chipscreen: Bio-Thera Solutions plans to reduce its holdings by no more than 3% of shares
Chipscreen announced that Boao Bio plans to reduce its holdings by no more than 3% in the next 6 months due to strategic planning needs, totaling 12.2339 million shares. The reduction will be carried out through a combination of centralized bidding and block trading, with no more than 1% reduction every 90 days during the centralized bidding period and no more than 2% reduction every 90 days during the block trading period
According to the announcement from Zhitong Finance APP, Chipscreen (688321.SH) has announced that due to funding needs for strategic planning, Boao Biology plans to reduce its holdings in the company by no more than 12.2339 million shares (i.e., no more than 3% of the company's total share capital) within six months after the announcement date, through a combination of centralized bidding and block trading. If using centralized bidding, the total number of shares reduced within any consecutive 90 days shall not exceed 1% of the total number of shares of the company; if using block trading, the total number of shares reduced within any consecutive 90 days shall not exceed 2% of the total number of shares of the company
